Clinical Trial Update: Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of sorafenib with cisplatin and etoposide in extensive-stage small cell lung cancer was terminated. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Nexavar (Sorafenib)

Snippet

Sponsor: Afshin Dowlati, MD | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-04